Search

A prototype of an innovative device developed at Memorial Sloan Kettering for minimally invasive surgery in head, neck, and other cancers in confined spaces holds promise for helping patients around the globe.

… Thursday, December 1, 2011 Summary A prototype of an innovative device developed at Memorial Sloan Kettering for minimally invasive surgery in head, neck, and other cancers in confined spaces holds promise for helping patients around the globe. An expert on minimally invasive laser surgery, Snehal G.

Craig B. Thompson announced his intention to step down as President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center and has asked the Boards of Trustees and Governing Trustees to begin a search for his successor.

… Thursday, February 3, 2022 Today, Craig B. Thompson announced his intention to step down as President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center (MSK) and has asked the Boards of Trustees and Governing Trustees to begin a search for his successor. Thompson will continue in

Scientists have uncovered a surprising link between metabolism and gene control in T cells.

… Monday, November 7, 2016 Summary New research by scientists at the Sloan Kettering Institute finds a surprising link between metabolism and gene expression in T cells, raising implications for the treatment of cancer and autoimmune diseases. Highlights Immune cells use a form of metabolism called aerobic

Researchers at Memorial Sloan Kettering Cancer Center have shown for the first time that a tendency to develop some blood disorders may be inherited.

… Sunday, March 15, 2009 Researchers at Memorial Sloan Kettering Cancer Center (MSKCC) have shown for the first time that a tendency to develop some blood disorders may be inherited. Their research, published online today in Nature Genetics , identifies a common genetic sequence abnormality that enhances

It's not only what's inside your cells that determines your cancer risk. It's what surrounds them too.

… Tuesday, June 26, 2018 Summary Scientists are learning that inflammation can play a role in cancer development. This is one example of how the environment surrounding an abnormal cell can influence its fate. Growing up, Philipp Niethammer learned from his mother to never scratch his moles. “I am not

Endometrial tumors can be reclassified into distinct subtypes based partly on their genomic makeup and may respond to targeted drugs already being tested in clinical trials, according to a large-scale genomic analysis led by researchers at Memorial Sloan Kettering Cancer Center and other centers within The Cancer Genome Atlas Research Network.

… Wednesday, May 1, 2013 Endometrial tumors can be reclassified into distinct subtypes based partly on their genomic makeup and may respond to targeted drugs already being tested in clinical trials, according to a large-scale genomic analysis led by researchers at Memorial Sloan Kettering Cancer Center

An innovative 3D motion management platform for guiding stereotactic body radiation therapy (SBRT) significantly reduced late urinary toxicity in patients treated for prostate cancer compared to a commercial image-guidance system, according to study results presented October 2 at the ASTRO 2023 Annual Meeting in San Diego.

… Wednesday, October 11, 2023 An innovative 3D motion management platform for guiding stereotactic body radiation therapy (SBRT) significantly reduced late urinary toxicity in patients treated for prostate cancer compared to a commercial image-guidance system, according to  study results presented October

Learn how a new kind of CAR T cell therapy could be a major advance for treating acute myeloid leukemia.

… Monday, April 22, 2024 Acute myeloid leukemia (AML) is one of the most challenging blood cancers . The disease moves quickly and needs aggressive treatment with chemotherapy , sometimes followed by a  bone marrow transplant . Even when the first round of therapy works, AML often returns. Now a clinical

Memorial Sloan Kettering Cancer Center (MSK) was recently notified by a third-party software vendor, Accellion, Inc., of a technical vulnerability in a document-sharing system used at MSK. MSK was one of many Accellion customers whose document-sharing systems were involved in this incident. After a full investigation, we discovered that an unauthorized party was able to access and copy a subset of electronic documents stored on the system.

… Wednesday, March 31, 2021 Memorial Sloan Kettering Cancer Center (MSK) was recently notified by a third-party software vendor, Accellion, Inc., of a technical vulnerability in a document-sharing system used at MSK. MSK was one of many Accellion customers whose document-sharing systems were involved in

In recent years, there has been a shift toward capturing information about the side effects caused by new treatments directly from patients.

… Tuesday, February 26, 2019 Summary Patients’ reports on their symptoms and experiences are considered the gold standard for documenting side effects in clinical research. Memorial Sloan Kettering researchers oversee hundreds of clinical trials every year. Some of the most exciting and potentially revolutionary